logo
15:59 Feb 09

Caplin Point Laboratories Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
1758.40
-67.30 (-3.69%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Caplin Point Laboratories Ltd. Financials

Caplin Point Laboratories Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
1758.40
-67.30 (-3.69%)
15:59 Feb 09
Quality
image/svg+xml

70/100
High Financial Strength

Valuation
image/svg+xml

38/100
Mid Valuation

Technical

39/100
Technically Neutral

Strength

10

Weakness

6

Opportunity

1

Threats

0

19.32 %

ROE %

16.71 %

ROA %

80.74

EPS

365.25

BVPS

27.68 %

Net Profit Margin

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales
1061.29 1269.41 1466.73 1694.1 1937.47
Operating Expenses +
732.65 874.74 1025.67 1142.66 1290.54
Raw Material
389.39 589.43 710.15 798.73 732.28
Increase Decrease in Cost
82.35 -31.92 -46.94 -74.55 38.56
Other Manufacturing Expense
3.36 0 0 0 0
Employee Cost
102.53 115.3 136.99 143.59 177.72
Miscellaneous Expenses
674.16 996.17 1233.21 1392.73 1309.64
Operating Profit
328.64 394.67 441.06 551.44 646.93
Other Income
23.54 38.75 55.98 66.94 96.43
Depreciation
36.97 46.9 44.99 53.44 65.96
Interest
1.59 0.7 0.78 0.78 0.61
Profit before tax and exceptio..
313.62 385.82 451.27 564.16 676.79
Exceptional Items
0 0 0.08 0.27 -0.01
PBT
313.62 385.82 451.35 564.43 676.78
Provision for Taxation
62.19 77.37 74.36 103.01 135.69
Net Profit
251.43 308.45 376.99 461.42 541.09
NET Profit after MI
242.27 299.84 376.26 457.09 536.31
EPS
31.71 39.61 49.18 60.19 70.25
Operating Profit Margin (%)
30.97 31.09 30.07 32.55 33.39
Net Profit Margin (%)
22.83 23.62 25.65 26.98 27.68

Caplin Point Laboratories Ltd. Shareholding

All Data in Percentage (%)
Promoter - - - - -
FII - - - - -
Public - - - - -
MF - - - - -
Others
Shareholder Shares Holding %
Research 360 logo
Download Our App On: